Table 1.

The effect of SB-PS on subjects’ performance in the cognitive computerized tool

Cognitive composite score (points)	Baseline	6 weeks	12 weeks	P-value*
Memory recognition	80.60 ± 2.11	86.24 ± 2.07	87.36 ± 1.54	0.007
Memory recall	73.52 ± 2.55	81.12 ± 2.64	82.32 ± 2.30	0.015
Executive functions	72.36 ± 4.62	79.16 ± 4.36	82.64 ± 3.69	0.013
Mental flexibility	73.12 ± 4.64	79.32 ± 4.35	82.44 ± 3.53	0.029
Focused attention	85.20 ± 2.46	88.24 ± 2.45	90.28 ± 1.91	0.076
Sustained attention	82.04 ± 3.18	86.00 ± 2.52	87.76 ± 1.80	0.100
Visuospatial learning	60.72 ± 2.65	66.40 ± 4.08	67.88 ± 3.67	0.170
Spatial short-term memory	58.44 ± 2.93	63.44 ± 4.52	64.32 ± 4.17	0.423

Notes: Mean cognitive composite scores, at baseline and following 6 and 12 weeks of SB-PS administration are presented. Values are described as mean ± SE; n = 25.

^*Based on RM-ANOVA of the mean change between baseline and 6 and 12 weeks’ treatment.

Abbreviations: RM-ANOVA, repeated measures analysis of variance; SB-PS, soybean-derived phosphatidylserine; SE, standard error.